- Home
- ARCT vs BTQ Comparison
ARCT vs BTQ Comparison
Compare ARCT & BTQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARCT | BTQ |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | United States | Canada |
| Employees | N/A | 35 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.5M | 394.2M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARCT | BTQ |
|---|---|---|
| Price | $10.41 | $2.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $23.80 | $7.89 |
| AVG Volume (30 Days) | 736.3K | ★ 1.8M |
| Earning Date | 11-09-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | $763.72 |
| Revenue Next Year | $64.21 | $175.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.50 | $2.09 |
| 52 Week High | $24.14 | $12.90 |
Technical Indicators
Market Signals| Indicator | ARCT | BTQ |
|---|---|---|
| Relative Strength Index (RSI) | 36.07 | 31.16 |
| Support Level | $6.53 | N/A |
| Resistance Level | $17.85 | $3.40 |
| Average True Range (ATR) | 1.11 | 0.18 |
| MACD | -0.42 | -0.06 |
| Stochastic Oscillator | 4.67 | 1.67 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About BTQ BTQ Technologies Corp.
BTQ Technologies Corp is engaged in the development of computer-based technology related to post-quantum cryptography, particularly as it applies to blockchain and related technologies, and their protection from the emerging security risk of quantum computing. The company derives revenue from Software licensing. Geographically, the company has a presence in Canada, Taiwan, Australia, and the United States.